Agilent Technologies Inc (A)vsCheck-Cap Ltd. (MBAI)
A
Agilent Technologies Inc
$135.44
-2.12%
HEALTHCARE · Cap: $36.67B
MBAI
Check-Cap Ltd.
$1.53
-8.38%
HEALTHCARE · Cap: $10.67M
Smart Verdict
WallStSmart Research — data-driven comparison
A leads profitability with a 19.6% profit margin vs 0.0%. MBAI trades at a lower P/E of 2.1x. A earns a higher WallStSmart Score of 71/100 (B).
A
Strong Buy71
out of 100
Grade: B
MBAI
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.4%
Fair Value
$74.34
Current Price
$135.44
$61.10 premium
Intrinsic value data unavailable for MBAI.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 60.0% YoY
Strong operational efficiency at 23.7%
Attractively priced relative to earnings
Every $100 of equity generates 120 in profit
Conservative balance sheet, low leverage
Areas to Watch
Moderate valuation
Grey zone — moderate risk
Weak financial health signals
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on EPS Growth, Operating Margin. Profitability is solid with margins at 19.6% and operating margin at 23.7%. PEG of 1.28 suggests the stock is reasonably priced for its growth.
Bull Case : MBAI
The strongest argument for MBAI centers on P/E Ratio, Return on Equity, Debt/Equity.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : MBAI
The primary concerns for MBAI are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
A profiles as a mature stock while MBAI is a value play — different risk/reward profiles.
A carries more volatility with a beta of 1.26 — expect wider price swings.
A is growing revenue faster at 10.0% — sustainability is the question.
A generates stronger free cash flow (184M), providing more financial flexibility.
Bottom Line
A scores higher overall (71/100 vs 28/100), backed by strong 19.6% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Check-Cap Ltd.
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company is headquartered in Isfiya, Israel.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?